Microbiome and Inherited Retinal Degenerations
- PMID: 37024045
- DOI: 10.1016/j.ajpath.2023.03.005
Microbiome and Inherited Retinal Degenerations
Abstract
Inherited retinal degenerations (IRDs) represent a genetically and clinically heterogeneous group of progressive and visually debilitating disorders that can lead to irreversible visual loss. Our understanding of IRD pathogenesis at both the genetic and cellular levels has increased tremendously over the past two decades, but the exact pathogenic mechanisms remain incompletely understood. Enhanced understanding of the pathophysiology of these diseases can result in new treatment targets. Alterations in the human gut microbiome play a key role in the pathogenesis of many ocular and nonocular diseases, such as age-related macular degeneration, neurologic and metabolic disorders, and autoimmune conditions. The gut microbiome regulates the susceptibility of mice to develop experimental autoimmune uveitis, a model for autoimmune disease of the posterior portion of the eye elicited by the systemic response to retinal antigens. Because of the mounting evidence in favor of a role for local and systemic inflammatory and autoimmune-mediated components to IRD pathogenesis, this review presents the current knowledge of gut microbiome in IRDs and discusses the association between possible changes in gut microbiome and pathogenesis of these diseases, with special attention to their possible contribution to the inflammatory underpinnings of IRDs.
Copyright © 2023 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Predictive value of genetic testing for inherited retinal diseases in patients with suspected atypical autoimmune retinopathy.Am J Ophthalmol Case Rep. 2019 May 10;15:100461. doi: 10.1016/j.ajoc.2019.100461. eCollection 2019 Sep. Am J Ophthalmol Case Rep. 2019. PMID: 31193260 Free PMC article.
-
The double-edged sword of inflammation in inherited retinal degenerations: Clinical and preclinical evidence for mechanistically and prognostically impactful but treatable complications.Front Cell Dev Biol. 2023 Apr 13;11:1177711. doi: 10.3389/fcell.2023.1177711. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37123408 Free PMC article.
-
A Review of the Impact of Alterations in Gut Microbiome on the Immunopathogenesis of Ocular Diseases.J Clin Med. 2021 Oct 13;10(20):4694. doi: 10.3390/jcm10204694. J Clin Med. 2021. PMID: 34682816 Free PMC article. Review.
-
The role of the gut microbiome in eye diseases.Prog Retin Eye Res. 2023 Jan;92:101117. doi: 10.1016/j.preteyeres.2022.101117. Epub 2022 Sep 6. Prog Retin Eye Res. 2023. PMID: 36075807 Review.
-
Gut microbiome and autoimmune disorders.Clin Exp Immunol. 2022 Aug 19;209(2):161-174. doi: 10.1093/cei/uxac057. Clin Exp Immunol. 2022. PMID: 35652460 Free PMC article. Review.
Cited by
-
Unveiling the gut-eye axis: how microbial metabolites influence ocular health and disease.Front Med (Lausanne). 2024 May 10;11:1377186. doi: 10.3389/fmed.2024.1377186. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38799150 Free PMC article. Review.
-
The gut-eye axis: the retinal/ocular degenerative diseases and the emergent therapeutic strategies.Front Cell Neurosci. 2024 Sep 26;18:1468187. doi: 10.3389/fncel.2024.1468187. eCollection 2024. Front Cell Neurosci. 2024. PMID: 39391760 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous